Integra Lifesciences Holdings (IART) Enterprise Value (2009 - 2026)

Integra Lifesciences Holdings has disclosed Enterprise Value across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 59.85% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 59.85% YoY), while the FY2025 annual figure was $704.2 million, down 52.34% from the prior year.
• Enterprise Value came in at $1.1 billion for Q2 2026 at Integra Lifesciences Holdings, up from $467.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $4.9 billion in Q1 2022 to a low of $467.3 million in Q1 2026.
• Average Enterprise Value over 5 years is $2.3 billion, with a median of $2.0 billion recorded in 2024.
• The largest YoY upside for Enterprise Value was 59.85% in 2026 against a maximum downside of 67.45% in 2026.
• Over 5 years, Enterprise Value stood at $4.1 billion in 2022, then slipped by 24.83% to $3.1 billion in 2023, then slumped by 52.29% to $1.5 billion in 2024, then slumped by 52.34% to $704.2 million in 2025, then surged by 59.42% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $1.1 billion in Q2 2026, $467.3 million in Q1 2026, and $704.2 million in Q4 2025.